Why the study?
Does subcutaneous low-dose heparin reduce postoperative deep-vein thrombosis in patients undergoing total hip replacement?
Population
143 patients undergoing total hip replacement
Comparison
Subcutaneous low-dose heparin vs Control group
Design
RCT, Randomized
Follow-up
7 to 15 days postoperatively
Authors
Loading...
Supports low-dose heparin for DVT prevention after hip replacement; confirms benefit in this surgical population.
Does subcutaneous low-dose heparin reduce postoperative deep-vein thrombosis in patients undergoing total hip replacement?
Subcutaneous low-dose heparin reduces the incidence of DVT after total hip replacement but significantly increases the risk of severe postoperative bleeding and transfusion requirements.
Mannucci et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: